家禽用ワクチンの世界市場規模：製品タイプ別、疾患タイプ別、投与形態別、用途別、地域別、範囲および予測

家禽用ワクチンの市場規模と予測

家禽用ワクチン市場規模は、2024年に21億5,000万米ドルと評価され、2026年から2032年にかけてCAGR 5.95%で成長し、2032年には34億2,000万米ドルに達すると予測されます。

• 家禽用ワクチンは、鶏、七面鳥、アヒル、その他の家禽類を感染症から守る生物学的製品です。
• ワクチンは鳥類の免疫システムを高めるように設計されており、ウイルスや細菌などの特定の病気に対する免疫力をつけることができます。
• さらに、家禽用ワクチンは、群れ内での病気の発生を防ぎ、鳥の健康状態を全般的に改善し、死亡率を下げ、家禽事業の生産量を増加させるために使用されます。また、効果的なワクチン接種プログラムは、鶏肉製品の消費を通じて家禽から人への病気の蔓延を抑えることで、食の安全を確保することにも役立っています。

家禽用ワクチンの世界市場力学

主な市場促進要因

• 鳥類疾病とバイオセキュリティに対する懸念の高まり：ニューカッスル病、鳥インフルエンザ、伝染性気管支炎ウイルス（IBV）は、世界の家禽部門に課題をもたらし続けており、その結果、鳥の死亡、鶏卵生産量の減少、貿易制限による経済的損失が発生しています。疾病の予防と管理にはワクチン接種が不可欠であり、これにより養鶏場のバイオセキュリティが向上します。こうした危険性とその経済的影響に関する知識の高まりが、効果的な家禽用ワクチンの需要を促進しています。
• 家禽肉への需要の増加と家禽群サイズの拡大：家禽肉は、その手頃な価格、健康上の利点、料理の多様性により、世界中で人気が高まっています。この動向は、生産需要を満たすために養鶏場の群れ規模を拡大することにつながります。しかし、群れが大きくなればなるほど、疾病感染の可能性が高まる。人口密度の高い地域では、伝染病を避け、群れの健康を維持するためにワクチン接種が不可欠となります。
• 食品の安全性と公衆衛生の重視：消費者は食品の安全性を重視し、鶏肉製品を通じて広がる病気を懸念しています。家禽のワクチン接種プログラムは、動物から人へ感染する人獣共通感染症の伝染を抑えることで、こうした危険を軽減します。健康な家禽の群れは、安全で高品質な食肉の安定供給を維持し、それは公衆衛生と業界のバイオセキュリティのためにワクチン接種を推進する政府のイニシアティブによって支えられています。

主な課題

• ワクチン接種の失敗とコールドチェーン管理：ワクチン接種の失敗は、効果的でない投与技術、誤ったワクチンの保管や輸送（コールドチェーンの破壊）、ワクチン接種を受けた鳥の免疫学的反応の不十分さなど、さまざまな理由で発生します。予防接種の試みにかかわらず、こうした失敗は疾病の発生につながります。このような問題に対処し、ワクチン接種の有効性を向上させるには、適切なワクチン接種方法を確保し、ワクチンの保管や輸送のための信頼できるコールドチェーンを維持し、より免疫原性の高いワクチンを製造する可能性があります。
• コストとワクチン接種プログラムの実施：ワクチン接種プログラムには、ワクチン、設備、訓練された作業員への投資が必要です。これは、養鶏農家、特に小規模で経営している養鶏農家にとっては経済的負担となります。また、大規模な養鶏場で効率的な予防接種プログラムを実施するには、入念な計画、ロジスティックス、バイオセキュリティの予防措置が必要です。費用対効果の高いワクチン接種方法の開発、農家への研修や技術支援の提供、ワクチン接種手順の合理化などはすべて、こうした困難を克服し、ワクチン接種の実施率を高めることに貢献します。

主要動向：

• 組み換えワクチンとベクターワクチンの開発：従来の家禽用ワクチンは不活化病原体を使用するが、組換えワクチンは特定の遺伝子を使用して免疫反応を引き起こし、ベクターワクチンは無害なウイルスを使用して防御抗原を送達します。これらの最新の方法は、より広範な保護を提供し、安全性を向上させ、鶏のワクチン接種における生産効率を高める可能性があります。
• In-ovoワクチン接種と自動化への注力：In-ovoワクチン接種では、胚化卵にワクチンを注入するため、従来の技術よりも早期にニワトリを保護し、より優れた免疫応答を得ることができます。自動ワクチン接種装置やデータシステムを含む自動化は、手順を合理化し、人件費を最小限に抑え、養鶏場全体で正確かつ一貫した予防接種を保証することを目的としています。
• 多剤併用ワクチン接種プログラムとワクチン接種モニタリングの台頭：多剤併用ワクチン接種プログラムは、新たな疾病と闘い、群れの健康を改善するために様々なワクチンを使用します。農家は、ワクチン接種率、抗体レベル、および疾病発生をリアルタイムで評価する高度なモニタリングツールを使用することにより、ワクチン接種戦術を最適化し、鶏の健康管理全体を強化することができます。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 家禽用ワクチン市場：製品タイプ別

• 改良または弱毒化（生ワクチン）
• 不活化（殺す）
• 組み換えワクチン

第5章 家禽用ワクチン市場：疾患タイプ別

• ニューカッスル病
• マレック病
• 感染性気管支炎
• 感染性滑液包炎
• その他

第6章 家禽用ワクチン市場：投与形態別

• 液体ワクチン
• フリーズドライワクチン
• ダクト

第6章 家禽用ワクチン市場：用途別

• ブリーダー
• ブロイラー
• レイヤー

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Ceva Sante Animale
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Venkys India Limited
• Phibro Animal Health Corporation
• Huvepharma AD
• Dechra Pharmaceuticals PLC

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Poultry Vaccines Market Size and Forecast

Poultry Vaccines Market size was valued at USD 2.15 Billion in 2024 and is projected to reach USD 3.42 Billion by 2032, growing at a CAGR of 5.95% from 2026 to 2032.

• Poultry vaccines are biological products that protect chickens, turkeys, ducks, and other poultry animals from infectious illnesses.
• The vaccines are designed to boost the immune system of birds, allowing them to build immunity to specific diseases such as viruses and bacteria.
• Furthermore, poultry vaccines are used to prevent disease outbreaks within flocks, improving general bird health, lowering mortality rates, and increasing production in the poultry business. Effective vaccination programs also help to ensure food safety by reducing the spread of diseases from poultry to humans through the consumption of chicken products.

Global Poultry Vaccines Market Dynamics

The key market dynamics that are shaping the poultry vaccines market include:

Key Market Drivers

• Rising Concerns About Avian Diseases and Biosecurity: Newcastle disease, Avian Influenza (bird flu), and Infectious Bronchitis Virus (IBV) continue to pose challenges to the worldwide poultry sector, resulting in economic losses due to bird death, lower egg production, and trade restrictions. Vaccination is critical for disease prevention and management, which improves biosecurity on chicken farms. Growing knowledge of these hazards and their economic consequences fuels the demand for effective poultry vaccines.
• Increasing Demand for Poultry Meat and Growing Flock Sizes: Poultry meat is becoming more popular worldwide due to its affordability, health benefits, and culinary variety. This trend leads to increased flock sizes on chicken farms to fulfill production demands. However, larger flocks increase the likelihood of disease transmission. Vaccination becomes critical in densely populated areas to avoid epidemics and keep flocks healthy.
• Focus on Food Safety and Public Health: Consumers value food safety and are concerned about diseases spread through poultry products. Poultry vaccination programs reduce these hazards by limiting the transmission of zoonotic illnesses, which are transmissible from animals to people. Healthy poultry flocks maintain a steady supply of safe, high-quality meat, which is aided by government initiatives to promote vaccination for public health and industry biosecurity.

Key Challenges:

• Vaccination Failures and Cold Chain Management: Vaccination failures occur for a variety of reasons, including ineffective administration techniques, wrong vaccine storage or transportation (breaking the cold chain), or insufficient immunological response in vaccinated birds. Regardless of immunization attempts, these failures result in disease outbreaks. Addressing this difficulty and improving vaccination efficacy can be accomplished by ensuring adequate vaccination practices, maintaining a dependable cold chain for vaccine storage and shipping, and potentially producing stronger immunogenic vaccines.
• Cost Considerations and Vaccination Program Implementation: Vaccination programs necessitate investments in vaccines, equipment, and trained workers. This is a financial strain for some poultry farmers, especially those operating on a small scale. Also, executing efficient immunization programs on big chicken farms necessitates careful planning, logistics, and biosecurity precautions. Developing cost-effective vaccination options, providing farmers with training and technical support, and streamlining vaccination procedures all contribute to overcoming these difficulties and increasing vaccination practice uptake.

Key Trends:

• Development of Recombinant Vaccines and Vector Vaccines: Traditional poultry vaccines use inactivated pathogens, while recombinant vaccines use particular genes to trigger an immune response, and vector vaccines use harmless viruses to deliver protective antigens. These modern methods provide broader protection, may improve safety, and increase production efficiency in chicken vaccination.
• Focus on In-ovo Vaccination and Automation: In-ovo vaccination involves injecting vaccines into embryonated eggs, resulting in earlier chick protection and better immune responses than traditional techniques. Automation, which includes automated vaccination devices and data systems, is intended to streamline procedures, minimize labor costs, and assure exact and consistent immunization throughout poultry farms.
• Rise of Multimodal Vaccination Programs and Vaccination Monitoring: Multimodal vaccination programs use various vaccines to battle emerging diseases and improve flock health. Farmers may optimize vaccination tactics and enhance overall chicken health management by using advanced monitoring tools to assess vaccination coverage, antibody levels, and disease outbreaks in real-time.

Global Poultry Vaccines Market Regional Analysis

Here is a more detailed regional analysis of the poultry vaccines market:

Asia Pacific:

• According to Verified Market Research, the Asia Pacific region is estimated to dominate the poultry vaccines market over the forecast period. The Asia-Pacific region has the world's largest poultry production sector, with China dominating both production and consumption of poultry meat. A flourishing chicken business requires a strong market for poultry vaccinations to protect flock health, improve biosecurity measures, and meet rising demand for safe poultry products.
• Governments around the Asia Pacific are becoming more aware of the economic and public health dangers posed by avian illnesses. Poultry farmers have become more conscious of the importance of vaccination programs for disease prevention and management. Government initiatives such as vaccine subsidies and planned vaccination campaigns help to boost market expansion.
• Furthermore, many of Asia Pacific's small and medium-sized chicken farms demand low-cost immunization alternatives. Vaccine makers in the region are reacting by developing cost-effective poultry vaccinations customized to local demands. Local production capabilities reduce reliance on imports, providing timely delivery and excellent cold chain management to keep vaccines effective.

North America:

• North America is estimated to exhibit substantial growth during the forecast period. North American chicken breeders follow strict biosecurity regulations and disease control procedures. Mandatory vaccination programs for certain chicken diseases are enforced, resulting in extensive vaccine use. The emphasis on biosecurity standards within the industry emphasizes preventive measures such as vaccination to reduce outbreak risks and maintain chicken flock health.
• North America leads in animal health research, which drives ongoing innovation in poultry vaccinations. Manufacturers are exploring recombinant vaccines, vector vaccines, and in-ovo immunization technologies to improve efficacy and convenience of delivery. These innovations enhance disease control capacities, hence improving overall poultry health management in the region.
• Furthermore, the North American poultry industry is progressively adopting precision livestock farming (PLF) technologies. PLF optimizes production through the use of sensors, analytics, and automation. Immunization programs connected with PLF systems allow for real-time monitoring of immunization status, bird health, and illness identification. This data-driven method improves vaccination effectiveness and disease management on poultry farms in North America.

Europe:

• European countries encourage preventative healthcare in animal husbandry, stressing immunization to limit disease transmission and dependency on medications. Stringent laws prohibit the use of antibiotics as growth boosters, emphasizing vaccines as the major strategy for keeping chickens healthy.
• European consumers are increasingly concerned with food safety and sustainability. Poultry vaccination programs reduce disease transmission, resulting in safe and reliable poultry products. Vaccination supports sustainable farming techniques by improving animal welfare and minimizing the environmental impact of antibiotic use.
• Furthermore, Europe is a leader in animal health research, which drives innovation in poultry vaccines. Advanced vaccines are effective against a wide range of diseases. Strict EU biosecurity laws require excellent cleanliness standards and disease control methods on chicken farms, with vaccination playing an important part in compliance and farm biosecurity.

Global Poultry Vaccines Market: Segmentation Analysis

The Poultry Vaccines Market is segmented based on Product Type, Disease Type, Dosage Form, Application, and Geography.

Poultry Vaccines Market, By Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

Based on the Product Type, the market is segmented into Modified or Attenuated, Inactivated, and Recombinants. The inactivated segment is estimated to dominate the poultry vaccines market due to their safety, acceptability for birds of all ages, and efficacy against a variety of poultry diseases. They benefit from existing production processes, possible cost savings, and regulatory acceptance based on their demonstrated efficacy and safety profile in preventing chicken illnesses.

Poultry Vaccines Market, By Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

Based on the Disease Type, the market is segmented into Newcastle Disease, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease, and Others. The Newcastle disease segment is estimated to dominate the poultry vaccines market during the forecast period due to its highly contagious nature and destructive impact on poultry. This avian paramyxovirus causes significant economic losses due to high mortality rates, reduced egg output, and probable trade restrictions. Many countries require ND vaccination to prevent its spread and protect poultry industries, as it is recognized as a concern worldwide. Continuous vaccination efforts against various strains of ND strengthen its market position.

Poultry Vaccines Market, By Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

Based on the Dosage Form, the market is segmented into Liquid Vaccine, Freeze Dried Vaccine, and Duct. The liquid vaccine segment is estimated to exhibit the highest growth within the poultry vaccines market owing to its ease of administration by drinking water, eye drops, or spray methods. This convenience makes liquid vaccinations ideal for bulk vaccination in large-scale chicken farms. Furthermore, their lower production costs compared to freeze-dried vaccines make them appealing to poultry farmers, particularly in areas with a high concentration of small to medium-sized enterprises. Liquid vaccines are especially well suited for broiler applications, where their rapid immune response matches the demands of shorter production cycles.

Poultry Vaccines Market, By Application

• Breeder
• Broiler
• Layer

Based on Application, the market is segmented into Breeder, Broiler, and Layer. The broiler segment is estimated to dominate the poultry vaccines market. Broiler chickens reared for meat have a limited lifespan and are housed in high densities, which increases disease transmission risks. Vaccination is critical in these situations to avoid epidemics and keep flocks healthy. Given the economic importance of the broiler business and its huge worldwide production volumes, effective vaccination programs are critical to reducing economic losses from disease outbreaks and assuring a steady supply of poultry meat.

Poultry Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Poultry Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. According to the VMR analyst, Asia Pacific is estimated to dominate during the forecasted period. The Asia Pacific region, led by major chicken producers such as China, is experiencing tremendous growth in the poultry business. This spike emphasizes the need for a strong poultry vaccine market to protect flock health and meet the growing demand for safe chicken products. Governments are actively pushing vaccination programs, financing vaccinations, and encouraging local production to ensure cost-effective solutions and disease control across a wide range of chicken farming environments.

Key Players

• The "Poultry Vaccines Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boehringer Ingelheim International GmbH, Zoetis, Inc., Ceva Sante Animale, Merck & Co., Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Venkys India Limited, Phibro Animal Health Corporation, Huvepharma AD, and Dechra Pharmaceuticals PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Poultry Vaccines Market Recent Developments
• In August 2022, Bimeda, an Ireland-based company specializing in veterinary medications and animal care products, purchased Afrivet for an unknown amount. With this acquisition, Bimeda will have the largest animal health company presence in Africa. Afrivet is a South African manufacturer of chicken vaccinations.
• In December 2021, Immuno-intelligent Limited, an Indian antibody maker, introduced a new goat pox vaccine to prevent disease. At 90 days old, a live, weakened antibody should be administered subcutaneously at a rate of 1 ml.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Poultry Vaccines Market, By Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

5. Poultry Vaccines Market, By Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

6. Poultry Vaccines Market, By Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

6. Poultry Vaccines Market, By Application

• Breeder
• Broiler
• Layer

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Ceva Sante Animale
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Venkys India Limited
• Phibro Animal Health Corporation
• Huvepharma AD
• Dechra Pharmaceuticals PLC

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References